It has become clear that targeted therapy is one of the best options for decreasing the unpleasant side
effects of existing common methods and reducing the number of deaths occurred due to many types of cancer.
Biocompatible and non-toxic delivery systems are provided by nanomedicine for aiding targeted therapy in
many diseases containing cancer. Cervical cancer (CC) is not only the most common gynecological cancer but
also is ranked as the fourth common cancer between both men and women. Chemotherapy, radiotherapy,
surgery, and immunotherapy are the approaches, which are being used for treating CC patients. However, more
efficacy of these methods can be achieved with the help of nanomedicine and novel delivery systems. Nanocellulose
is one of the agents used for designing these systems in order to deliver different drugs to a diversity of
cancerous cells. In this review, we aim to investigate the competency of nanocellulose for establishing novel
therapeutic methods for cervical cancer. We hope that our results help develop more drug delivery systems for
targeted therapy to reduce the side effects and induce the efficacy of anti-cancer drugs.
Keywords: Nanomedicine, nanocellulose, drug delivery, carboxymethyl cellulose, gynecological cancer, targeted therapy, cervical cancer.
Rights & PermissionsPrintExport